David Moller

David Moller

Company: Poxel Pharma

Job title: Chief Scientific Officer


Striking the Balance Between Quality & Efficiency: How to Devise a Fool Proof Plan to Maximize Convenience & Minimize Errors When Creating NASH Models for Biopharma 11:30 am

• Describing two novel pathways/first-in-class molecules with potential in NASH • Exploring alternative approaches to increasing the probability of success of translation to humans and leveraging available clinical data from a related molecule • Utilizing the 505(b)(2) regulatory pathwayRead more

day: Day 2 Stream 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.